Yi Sang 4

What Happened
Yi Sang, Group President, Asia Pacific for Zimmer Biomet (ZBH), was granted 7,050 restricted stock units (RSUs) on 2026-02-19. The filing lists the acquisition price as $0.00 (derivative award). These RSUs are performance-based awards earned for the 2023–2025 performance period and will vest on March 6, 2026.

Key Details

• Transaction type/code: Award/Grant (A) of RSUs (derivative).
• Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (filed within required two business days).
• Quantity and price: 7,050 RSUs acquired at $0.00.
• Vesting: All 7,050 RSUs will vest on March 6, 2026.
• Shares owned after transaction: Not specified in the Form 4.
• Footnotes:
  • F1: Each RSU represents a contingent right to receive one share of common stock upon vesting.
  • F2: These RSUs were performance-based grants originally awarded March 6, 2023 and September 1, 2023; the earned amounts (5,298 and 1,752 RSUs) were determined on 2/19/2026 based on actual performance for 2023–2025.

Context
RSUs are a form of equity compensation that convert into shares when they vest; no cash was paid by the insider at grant. Because these were performance-based RSUs earned for a prior performance period, the award reflects plan-determined payouts rather than an open-market purchase or sale by the insider.